Clinical Trial Update: Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing memory effects of gamma-hydroxybutyrate versus trazodone in major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Trazodone (trazodone)
• gamma-hydroxybutyrate (gamma-hydroxybutyric acid)

Snippet

Sponsor: Erich Seifritz | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED